Anti-Myogenin antibody [SQab20208] (STJ16102968)

SPECIFICATIONS
ClonalityMonoclonal
HostRabbit
ConjugationUnconjugated
ImmunogenSynthetic peptide within aa. 100-200 of Human Myogenin.
STJ16102968-100
๐Ÿšš Free UK Delivery on orders over ยฃ150
Processing The item has been added
Enquire For Bulk Order
✓ 1-Year Performance Guarantee | SDS & Datasheet Included | Expert Tech Support | Covered by St John's Laboratory Guarantee

General Information

Short DescriptionRabbit monoclonal anti-Myogenin for use in IHC-P in Human samples. Datasheet included with dilution recommendations, and related reagents.
ApplicationsIHC-P
HostRabbit
ReactivityHuman
NoteSTRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.

Product Properties

ClonalityMonoclonal
Clone IDSQab20208
ConjugationUnconjugated
PurificationPurification with Protein A.
FormulationPBS, 0.01% Sodium azide, 40% Glycerol and 0.05% BSA.
Storage InstructionStore at-20ยฐC for up to 1 year. Minimise freeze-thaw cycles.

Target Information

Gene SymbolMYOG
Gene ID4656
Uniprot IDMYOG_HUMAN
ImmunogenSynthetic peptide within aa. 100-200 of Human Myogenin.

Additional Info

Function Acts as a transcriptional activator that promotes transcription of muscle-specific target genes and plays a role in muscle differentiation, cell cycle exit and muscle atrophy. Essential for the development of functional embryonic skeletal fiber muscle differentiation. However is dispensable for postnatal skeletal muscle growth.phosphorylation by CAMK2G inhibits its transcriptional activity in respons to muscle activity. Required for the recruitment of the FACT complex to muscle-specific promoter regions, thus promoting gene expression initiation. During terminal myoblast differentiation, plays a role as a strong activator of transcription at loci with an open chromatin structure previously initiated by MYOD1. Together with MYF5 and MYOD1, co-occupies muscle-specific gene promoter core regions during myogenesis. Also cooperates with myocyte-specific enhancer factor MEF2D and BRG1-dependent recruitment of SWI/SNF chromatin-remodeling enzymes to alter chromatin structure at myogenic late gene promoters. Facilitates cell cycle exit during terminal muscle differentiation through the up-regulation of miR-20a expression, which in turn represses genes involved in cell cycle progression. Binds to the E-box containing (E1) promoter region of the miR-20a gene. Also plays a role in preventing reversal of muscle cell differentiation. Contributes to the atrophy-related gene expression in adult denervated muscles. Induces fibroblasts to differentiate into myoblasts.
Protein Name Myogenin
Class C Basic Helix-Loop-Helix Protein 3
Bhlhc3
Myogenic Factor 4
Myf-4
Database Links Reactome: R-HSA-525793
Reactome: R-HSA-9839394
Cellular Localisation Nucleus
Recruited To Late Myogenic Gene Promoter Regulatory Sequences With Smarca4/Brg1/Baf190a And Swi/Snf Chromatin-Remodeling Enzymes To Promote Chromatin-Remodeling And Transcription Initiation In Developing Embryos
Alternative Antibody Names Anti-Myogenin antibody
Anti-Class C Basic Helix-Loop-Helix Protein 3 antibody
Anti-Bhlhc3 antibody
Anti-Myogenic Factor 4 antibody
Anti-Myf-4 antibody
Anti-MYOG antibody
Anti-BHLHC3 antibody
Anti-MYF4 antibody

Information sourced from Uniprot.org

Citations

Product Review